EP1482922A4 - AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS - Google Patents
AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERSInfo
- Publication number
- EP1482922A4 EP1482922A4 EP03711552A EP03711552A EP1482922A4 EP 1482922 A4 EP1482922 A4 EP 1482922A4 EP 03711552 A EP03711552 A EP 03711552A EP 03711552 A EP03711552 A EP 03711552A EP 1482922 A4 EP1482922 A4 EP 1482922A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- corneal
- treat
- eye
- agents
- prevent disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36397902P | 2002-03-14 | 2002-03-14 | |
US363979P | 2002-03-14 | ||
PCT/US2003/007700 WO2003077898A1 (en) | 2002-03-14 | 2003-03-14 | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1482922A1 EP1482922A1 (en) | 2004-12-08 |
EP1482922A4 true EP1482922A4 (en) | 2005-06-08 |
Family
ID=28041849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03711552A Withdrawn EP1482922A4 (en) | 2002-03-14 | 2003-03-14 | AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1482922A4 (ru) |
JP (1) | JP2005522464A (ru) |
KR (1) | KR20040094793A (ru) |
CN (1) | CN1642536A (ru) |
AU (2) | AU2003213858A1 (ru) |
BR (1) | BR0308403A (ru) |
CA (1) | CA2478965A1 (ru) |
MX (1) | MXPA04008776A (ru) |
RU (1) | RU2363459C2 (ru) |
WO (1) | WO2003077898A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030199574A1 (en) | 2000-03-02 | 2003-10-23 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
CN101231121B (zh) * | 2007-01-24 | 2012-06-13 | 泰州乐金电子冷机有限公司 | 冰箱用托盘拉出装置 |
CN102859344A (zh) * | 2010-03-12 | 2013-01-02 | 独立行政法人理化学研究所 | 用于生物材料的澄清试剂和其用途 |
US10444124B2 (en) | 2011-05-20 | 2019-10-15 | Riken | Clarifying reagent for biological materials and use thereof |
JP6433901B2 (ja) | 2013-08-14 | 2018-12-05 | 国立研究開発法人理化学研究所 | 光透過性に優れた生物材料を調製するための組成物およびその利用 |
DE102013110608A1 (de) * | 2013-09-26 | 2015-03-26 | Florian Lang | Substanz zur Hemmung von Gewebskalzifizierung, Gewebsfibrosierung und altersassoziierten Erkrankungen |
CN110237238A (zh) * | 2019-08-02 | 2019-09-17 | 山东省眼科研究所 | Manf在促进角膜损伤修复中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051620A1 (en) * | 1999-03-02 | 2000-09-08 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
WO2003068166A2 (en) * | 2002-02-13 | 2003-08-21 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5470881A (en) * | 1993-09-09 | 1995-11-28 | West Virginia University Research Corporation | Urea ophthalmic ointment and solution |
-
2003
- 2003-03-14 MX MXPA04008776A patent/MXPA04008776A/es not_active Application Discontinuation
- 2003-03-14 RU RU2004129761/14A patent/RU2363459C2/ru not_active Application Discontinuation
- 2003-03-14 CA CA002478965A patent/CA2478965A1/en not_active Abandoned
- 2003-03-14 KR KR10-2004-7014329A patent/KR20040094793A/ko not_active Application Discontinuation
- 2003-03-14 JP JP2003575951A patent/JP2005522464A/ja active Pending
- 2003-03-14 CN CNA038059681A patent/CN1642536A/zh active Pending
- 2003-03-14 WO PCT/US2003/007700 patent/WO2003077898A1/en active Application Filing
- 2003-03-14 BR BR0308403-5A patent/BR0308403A/pt not_active Application Discontinuation
- 2003-03-14 EP EP03711552A patent/EP1482922A4/en not_active Withdrawn
- 2003-03-14 AU AU2003213858A patent/AU2003213858A1/en not_active Abandoned
-
2009
- 2009-05-13 AU AU2009201897A patent/AU2009201897B2/en not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051620A1 (en) * | 1999-03-02 | 2000-09-08 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
WO2003068166A2 (en) * | 2002-02-13 | 2003-08-21 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
Non-Patent Citations (1)
Title |
---|
See also references of WO03077898A1 * |
Also Published As
Publication number | Publication date |
---|---|
BR0308403A (pt) | 2005-01-18 |
CN1642536A (zh) | 2005-07-20 |
WO2003077898A1 (en) | 2003-09-25 |
MXPA04008776A (es) | 2005-04-19 |
CA2478965A1 (en) | 2003-09-25 |
RU2004129761A (ru) | 2005-06-10 |
AU2003213858A1 (en) | 2003-09-29 |
JP2005522464A (ja) | 2005-07-28 |
KR20040094793A (ko) | 2004-11-10 |
RU2363459C2 (ru) | 2009-08-10 |
EP1482922A1 (en) | 2004-12-08 |
AU2009201897A1 (en) | 2009-06-04 |
AU2009201897B2 (en) | 2011-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1592435A4 (en) | EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS | |
GB0404693D0 (en) | Pharmaceutical preparations for the treatment of ocular surface and other disorders | |
SI1660057T1 (sl) | Kombinirana terapija za zdravljenje okularnih neovaskularnih nepravilnosti | |
FI9630U1 (fi) | Järjestelmä potilaan silmän verkkokalvon hoitamiseksi laserilla | |
SI1765322T1 (sl) | Derivati retinala in postopki za njihovo uporabo za zdravljenje motenj vida | |
TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
IL190295A0 (en) | Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders | |
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
MX2010003774A (es) | Formulaciones oftalmicas acuosas. | |
WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
GB2402674B (en) | Compositions and methods for the treatment of glaucoma or ocular hypertension | |
EP1631297A4 (en) | TREATMENT OF IMMUNOSTIC DISEASES WITH ACTIVE VITAMIN D COMPOUNDS ALONE OR IN COMBINATION WITH OTHER THERAPEUTICS | |
WO2004012762A3 (en) | Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels | |
HUP0401605A3 (en) | Integrin inhibitors for the treatment of eye diseases | |
MX2007004030A (es) | Analogos de poliamina como agentes terapeuticos para enfermedades oculares. | |
WO2002079169A8 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
WO2002079149A3 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
DK1614419T3 (da) | Midler til forebyggelse/behandling af retinale nervesygdomme, indeholdende alkyletherderivater eller salte deraf | |
EP1542664A4 (en) | METHODS AND COMPOSITIONS FOR TREATING MACULAR AND RETINAL DISORDERS | |
HUP0302718A3 (en) | Methods and compositions for the treatment of diseases of the eye | |
PL378210A1 (pl) | Zastosowanie steroidów do leczenia osób cierpiących z powodu zaburzeń gałki ocznej | |
EP1482922A4 (en) | AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS | |
EP1406648A4 (en) | USE OF ANGIOTENSIN I DERIVATIVE AGENT FOR THE TREATMENT AND PREVENTION OF INFECTIOUS HEART DAMAGE AND DISEASES | |
WO2005016327A3 (en) | Treatment of sleep disorders with cholinesterase inhibitors | |
MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040901 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050421 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 27/06 B Ipc: 7A 61K 31/40 B Ipc: 7A 61K 31/17 A |
|
17Q | First examination report despatched |
Effective date: 20060119 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RTI1 | Title (correction) |
Free format text: AGENTS FOR CORNEAL ADMINISTRATION TO TREAT OR PREVENT DISORDERS OF THE EYE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100310 |